![Elaine Benaksas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Elaine Benaksas
Corporate Officer/Principal chez American Chemical Society
Postes actifs de Elaine Benaksas
Sociétés | Poste | Début | Fin |
---|---|---|---|
American Chemical Society
![]() American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Corporate Officer/Principal | - | - |
Historique de carrière de Elaine Benaksas
Anciens postes connus de Elaine Benaksas
Sociétés | Poste | Début | Fin |
---|---|---|---|
Encore Pharmaceuticals, Inc.
![]() Encore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encore Pharmaceuticals, Inc. (EPI) is a drug discovery and development company with advanced proprietary products for the treatment and prevention of cancer and neurologic and cardiovascular diseases. EPI's principal drug innovations have come from discoveries made by researchers at Loma Linda University Medical Center (LLUMC). EPI was founded in 1997 and concluded a technology transfer license agreement with LLUMC in January 1999. The discovery operation continues to be located in the LLUMC environment where operations in 1999 were expanded to include clinical development of EPI's lead drug candidate E-7869 (now known as MPC-7869) for treatment of prostate and colon cancer. The company's research efforts have also led to the discovery of a -tocopherol (member of the Vitamin E family) metabolite designated as E-8110 (also known as LLU- ) and bioanalogs which have natriuretic (sodium excretion) activity. These compounds are being examined for their anti-hypertensive, anti-oxidant and anti-cancer properties. Patent applications for EPI drug discoveries have been filed and are in review worldwide | Directeur Technique/Scientifique/R&D | 17/12/2010 | - |
Loma Linda University | Corporate Officer/Principal | - | - |
Formation de Elaine Benaksas
University of California, Los Angeles | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Commercial Services | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
American Chemical Society
![]() American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |
Encore Pharmaceuticals, Inc.
![]() Encore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encore Pharmaceuticals, Inc. (EPI) is a drug discovery and development company with advanced proprietary products for the treatment and prevention of cancer and neurologic and cardiovascular diseases. EPI's principal drug innovations have come from discoveries made by researchers at Loma Linda University Medical Center (LLUMC). EPI was founded in 1997 and concluded a technology transfer license agreement with LLUMC in January 1999. The discovery operation continues to be located in the LLUMC environment where operations in 1999 were expanded to include clinical development of EPI's lead drug candidate E-7869 (now known as MPC-7869) for treatment of prostate and colon cancer. The company's research efforts have also led to the discovery of a -tocopherol (member of the Vitamin E family) metabolite designated as E-8110 (also known as LLU- ) and bioanalogs which have natriuretic (sodium excretion) activity. These compounds are being examined for their anti-hypertensive, anti-oxidant and anti-cancer properties. Patent applications for EPI drug discoveries have been filed and are in review worldwide | Health Technology |
- Bourse
- Insiders
- Elaine Benaksas
- Expérience